These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 27316540)
1. Proteasome inhibition by new dual warhead containing peptido vinyl sulfonyl fluorides. Brouwer AJ; Herrero Álvarez N; Ciaffoni A; van de Langemheen H; Liskamp RM Bioorg Med Chem; 2016 Aug; 24(16):3429-35. PubMed ID: 27316540 [TBL] [Abstract][Full Text] [Related]
2. Peptido sulfonyl fluorides as new powerful proteasome inhibitors. Brouwer AJ; Jonker A; Werkhoven P; Kuo E; Li N; Gallastegui N; Kemmink J; Florea BI; Groll M; Overkleeft HS; Liskamp RM J Med Chem; 2012 Dec; 55(24):10995-1003. PubMed ID: 23170994 [TBL] [Abstract][Full Text] [Related]
3. Potential peptidic proteasome inhibitors by incorporation of an electrophilic trap based on amino acid derived α-substituted sulfonyl fluorides. Herrero Alvarez N; van de Langemheen H; Brouwer AJ; Liskamp RMJ Bioorg Med Chem; 2017 Oct; 25(19):5055-5063. PubMed ID: 28734665 [TBL] [Abstract][Full Text] [Related]
4. Potent and Highly Selective Inhibitors of the Proteasome Trypsin-like Site by Incorporation of Basic Side Chain Containing Amino Acid Derived Sulfonyl Fluorides. Artschwager R; Ward DJ; Gannon S; Brouwer AJ; van de Langemheen H; Kowalski H; Liskamp RMJ J Med Chem; 2018 Jun; 61(12):5395-5411. PubMed ID: 29782167 [TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of the immunoproteasome by ligand-induced crosslinking of the active site. Dubiella C; Cui H; Gersch M; Brouwer AJ; Sieber SA; Krüger A; Liskamp RM; Groll M Angew Chem Int Ed Engl; 2014 Oct; 53(44):11969-73. PubMed ID: 25244435 [TBL] [Abstract][Full Text] [Related]
6. Activation-Free Sulfonyl Fluoride Probes for Fragment Screening. Petri L; Ábrányi-Balogh P; Csorba N; Keeley A; Simon J; Ranđelović I; Tóvári J; Schlosser G; Szabó D; Drahos L; Keserű GM Molecules; 2023 Mar; 28(7):. PubMed ID: 37049805 [TBL] [Abstract][Full Text] [Related]
7. Development of novel peptidomimetics containing a vinyl sulfone moiety as proteasome inhibitors. Ettari R; Bonaccorso C; Micale N; Heindl C; Schirmeister T; Calabrò ML; Grasso S; Zappalà M ChemMedChem; 2011 Jul; 6(7):1228-37. PubMed ID: 21506279 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biochemical Evaluation of Warhead-Decorated Psoralens as (Immuno)Proteasome Inhibitors. Schiffrer ES; Proj M; Gobec M; Rejc L; Šterman A; Mravljak J; Gobec S; Sosič I Molecules; 2021 Jan; 26(2):. PubMed ID: 33445542 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of peptide proline-boronic acids as proteasome inhibitors. Han L; Wen Y; Li R; Xu B; Ge Z; Wang X; Cheng T; Cui J; Li R Bioorg Med Chem; 2017 Aug; 25(15):4031-4044. PubMed ID: 28634039 [TBL] [Abstract][Full Text] [Related]
11. Development of a new class of proteasome inhibitors with an epoxyketone warhead: Rational hybridization of non-peptidic belactosin derivatives and peptide epoxyketones. Kawamura S; Unno Y; Asai A; Arisawa M; Shuto S Bioorg Med Chem; 2014 Jun; 22(12):3091-5. PubMed ID: 24814885 [TBL] [Abstract][Full Text] [Related]
12. Discovery of a potent and highly β1 specific proteasome inhibitor from a focused library of urea-containing peptide vinyl sulfones and peptide epoxyketones. van der Linden WA; Willems LI; Shabaneh TB; Li N; Ruben M; Florea BI; van der Marel GA; Kaiser M; Kisselev AF; Overkleeft HS Org Biomol Chem; 2012 Jan; 10(1):181-94. PubMed ID: 22105930 [TBL] [Abstract][Full Text] [Related]
13. Fluoride-mediated elimination of allyl sulfones: application to the synthesis of a 2,4-dimethyl-A-ring vitamin D3 analogue. Sikervar V; Fleet JC; Fuchs PL J Org Chem; 2012 Jun; 77(11):5132-8. PubMed ID: 22533543 [TBL] [Abstract][Full Text] [Related]
14. Exploring dual electrophiles in peptide-based proteasome inhibitors: carbonyls and epoxides. Xin BT; de Bruin G; Verdoes M; Filippov DV; van der Marel GA; Overkleeft HS Org Biomol Chem; 2014 Aug; 12(30):5710-8. PubMed ID: 24968066 [TBL] [Abstract][Full Text] [Related]
15. Nature of pharmacophore influences active site specificity of proteasome inhibitors. Screen M; Britton M; Downey SL; Verdoes M; Voges MJ; Blom AE; Geurink PP; Risseeuw MD; Florea BI; van der Linden WA; Pletnev AA; Overkleeft HS; Kisselev AF J Biol Chem; 2010 Dec; 285(51):40125-34. PubMed ID: 20937826 [TBL] [Abstract][Full Text] [Related]
16. Tunable Probes with Direct Fluorescence Signals for the Constitutive and Immunoproteasome. Dubiella C; Cui H; Groll M Angew Chem Int Ed Engl; 2016 Oct; 55(42):13330-13334. PubMed ID: 27709817 [TBL] [Abstract][Full Text] [Related]
17. Theoretical study of the inhibition mechanism of human 20S proteasome by dihydroeponemycin. Serrano-Aparicio N; Świderek K; Moliner V Eur J Med Chem; 2019 Feb; 164():399-407. PubMed ID: 30611981 [TBL] [Abstract][Full Text] [Related]
18. Macyranones: Structure, Biosynthesis, and Binding Mode of an Unprecedented Epoxyketone that Targets the 20S Proteasome. Keller L; Plaza A; Dubiella C; Groll M; Kaiser M; Müller R J Am Chem Soc; 2015 Jul; 137(25):8121-30. PubMed ID: 26050527 [TBL] [Abstract][Full Text] [Related]
19. Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasome. Desvergne A; Genin E; Maréchal X; Gallastegui N; Dufau L; Richy N; Groll M; Vidal J; Reboud-Ravaux M J Med Chem; 2013 Apr; 56(8):3367-78. PubMed ID: 23540790 [TBL] [Abstract][Full Text] [Related]
20. Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors. Rydzewski RM; Burrill L; Mendonca R; Palmer JT; Rice M; Tahilramani R; Bass KE; Leung L; Gjerstad E; Janc JW; Pan L J Med Chem; 2006 May; 49(10):2953-68. PubMed ID: 16686537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]